Sat, Dec 27, 2014, 6:52 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

K-V Pharmaceutical Company Message Board

  • rosenbaumtom70 rosenbaumtom70 Nov 9, 2011 2:46 PM Flag

    IGXT (Mcap 28 M) // Approval date 10 Nov 2011

     

    LAST CHANCE TO GET IN BEFORE FDA APPROVAL .PRICE TARGET 2++ DOLLAR TOMORROW FOLKS ! GLTA


    Intelgenx (IGXT.OB)

    Market Cap : 28 M$
    Cash: 3.7 M$
    Price : 0,58 $

    Shares Out : 45 M ( 23 M shares are held by Insiders + Institutions)


    FDA Revises IntelGenx' CPI-300 PDUFA Date to November 10th

    SAINT LAURENT, Quebec, Nov. 7, 2011 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX.V - News) (OTCBB:IGXT.OB - News) ("IntelGenx") today announced that the U.S. Food and Drug Administration ("FDA") has revised the CPI-300 Prescription Drug User Fee Act ("PDUFA") date to November 10th, 2011 from their previous guidance of November 13th, 2011. CPI-300 is a novel, high strength of Bupropion Hydrochloride (HCl), the active ingredient in Wellbutrin XL(R).









    4r324t43t4t34z43

    This topic is deleted.
 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Rice Energy Inc.
NYSEFri, Dec 26, 2014 4:02 PM EST